The iPhone Effect in Healthcare: How Mounjaro is Rewriting the Economics of the Indian Pharmaceutical Market | Today’s news

Truth in numbers

The numbers underline the speed with which the category has taken off. Launched in India in March 2025, Mounjaro recorded sales ₹923 crore by 2025-26, according to data from Pharmarack, an e-commerce market audit firm. Sales over the last 12 months to September 2026 were approx ₹1,736 million. The total GLP-1 market was fixed ₹2,596 crore during the same period, with injectables accounting for about 86% of the value.